CEBPA and neoplasm: Herein, we developed a tTR14-decorated tFNA nanocarrier to specifically deliver exogenous saRNA targeting the CEBPA gene (CEBPA-saRNA) to pancreatic cancer cells, aiming to activate the tumor suppressor CEBPA and its downstream effectors to inhibit tumor cell proliferation.